FA
CLB icon

FDx Advisors’s Core Laboratories CLB Stock Holding History

FDx Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,411
Closed -$335K – 656
2019
Q2 		$335K Sell
6,411
-2,111
-25% -$124K 0.01% 598
2019
Q1 		$587K Buy
8,522
+4,431
+108% +$297K 0.02% 429
2018
Q4 		$244K Sell
4,091
-8,232
-67% -$710K 0.02% 471
2018
Q3 		$1.43M Buy
12,323
+1,257
+11% +$142K 0.05% 271
2018
Q2 		$1.4M Sell
11,066
-1,779
-14% -$217K 0.05% 297
2018
Q1 		$1.39M Sell
12,845
-3,418
-21% -$378K 0.04% 403
2017
Q4 		$1.78M Sell
16,263
-139
-0.8% -$13.9K 0.05% 349
2017
Q3 		$1.62M Buy
16,402
+2,167
+15% +$210K 0.04% 381
2017
Q2 		$1.44M Buy
14,235
+1,404
+11% +$151K 0.04% 412
2017
Q1 		$1.48M Buy
12,831
+559
+5% +$65K 0.05% 393
2016
Q4 		$1.47M Buy
12,272
+3,966
+48% +$439K 0.04% 381
2016
Q3 		$933K Buy
8,306
+1,119
+16% +$129K 0.04% 409
2016
Q2 		$890K Sell
7,187
-532
-7% -$64.2K 0.04% 400
2016
Q1 		$868K Buy
7,719
+828
+12% +$86K 0.04% 407
2015
Q4 		$749K Buy
6,891
+4,711
+216% +$539K 0.03% 439
2015
Q3 		$218K Sell
2,180
-3,478
-61% -$378K 0.02% 696
2015
Q2 		$666K Buy
5,658
+2,858
+102% +$347K 0.03% 475
2015
Q1 		$291K Sell
2,800
-13,842
-83% -$1.47M 0.01% 1238
2014
Q4 		$2M Sell
16,642
-466
-3% -$61.2K 0.12% 152
2014
Q3 		$2.5M Buy
17,108
+2,628
+18% +$406K 0.16% 128
2014
Q2 		$2.42M Buy
14,480
+5,015
+53% +$892K 0.16% 138
2014
Q1 		$1.88M Buy
9,465
+4,372
+86% +$825K 0.16% 148
2013
Q4 		$972K Buy
5,093
+3,482
+216% +$648K 0.1% 205
2013
Q3 		$273K Sell
1,611
-815
-34% -$127K 0.03% 479
2013
Q2 		$368K Buy
+2,426
New +$344K 0.05% 326

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

FDx Advisors's CLB Position: Q3 2019 in Review

FDx Advisors sold out of Core Laboratories (CLB) in Q3 2019, closing a stake of 6,411 shares — an estimated $335K sold.

FDx Advisors first reported a position in CLB in Q2 2013 and held it in 25 quarters. The position peaked at $2.5M in Q3 2014. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

  • FDx Advisors reported no remaining Core Laboratories position as of Q3 2019 after selling out during the quarter.
  • FDx Advisors sold 6,411 Core Laboratories shares in Q3 2019, an estimated $335K.
  • FDx Advisors first reported a position in Core Laboratories in Q2 2013 and held it in 25 quarters.
  • FDx Advisors's Core Laboratories position peaked at $2.5M in Q3 2014.
  • 274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on FDx Advisors's 13F filing for Q3 2019, filed 7 Nov 2019.